Exploring how state opioid policies affect pregnant women and newborns
State-level opioid policies and policies that regulate substance use duringpregnancy: a mixed methods exploration of their effects on maternal and infantoutcomes
This study looks at how different laws about opioids in each state affect pregnant women who use these medications and the health of their babies, helping us understand what works best for keeping both moms and newborns healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10877706 on NIH RePORTER |
What this research studies
This research investigates the impact of state-level opioid policies and regulations on substance use during pregnancy, focusing on their effects on maternal and infant health outcomes. By analyzing Medicaid and commercial insurance databases, the study aims to understand how different policies influence opioid use among pregnant women and the health of their newborns. The research will systematically map and categorize prenatal opioid policies across all 50 states from 2011 to 2020, providing a comprehensive dataset for analysis. The goal is to identify both the separate and combined effects of these policies on opioid use disorder and neonatal outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant women who are prescribed opioids or are at risk of opioid use disorder.
Not a fit: Patients who are not pregnant or who do not have any history of opioid use may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved policies that enhance the health outcomes of pregnant women and their infants affected by opioid use.
How similar studies have performed: Previous research has shown that policy changes can significantly impact health outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Martins, Silvia Saboia — Columbia University Health Sciences
- Study coordinator: Martins, Silvia Saboia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.